Characteristics of Patients treated with Immunotherapy alone which resulted in Prolonged Stable Disease

  • The AIET alone without other treatments has been administered to 11 patients with advanced stage of cancers (1).
  1. Breast cancer patients with bone and liver metastases could survive beyond 15 months
  2. Uterus cancer patients with Lymph node and colon metastases could live beyond 15 months, Stomach, Uterus and Esophagus cancer patients, all with lymph node metastases could live beyond 14 months.
  3. Ovarian cancer patients could live beyond 26 months and lung cancer patients beyond 22 months.
  4. Liver cancer patients could live beyond 12 months
  • An inoperable pancreatic cancer patient after 4 transfusions of AIET alone could survive upto 2 years (2).
  • 13 out of 46 patients with advanced pancreatic tumour were administered Immunocell treatment alone. These patients had a 50% survival time of 14.5 months(3)

 All the above underwent immunotherapy alone.

  • Goto et al., “Clinical Benefit of Non-toxic Therapy in Patients with Advanced Cancer (Opinion)”, Anti Cancer Res2002 22
  • Sivaraman G, Pandian A,Baskar S, Senthil KR, Senthilnagarajan R, Dedeepiya V, Abraham S, “Autologous Immune Enhancement therapy for advanced carcinoma of pancreas a case report”, PASRM, III annual symposium , 2008

  • Toru Kaneko, Shigenori Goto, Akira Kato, Akiteru Akeyama3, Masamichi Tomonaga, Katsunada Fujimoto, Yoju Miyamoto, Masazumi Eriguchi and Koji Egawa. Efficacy of immuno-cell Therapy in patients with Advanced Pancreatic Cancer. Anticancer Research 25: 3709-3714(2005)